SCHEMBL19983907

SCHEMBL19983907

CNCc1cn(Sc2cccc(OC)c2)c2cc(Nc3ccc(Cl)cc3F)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR1 P21462 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPT P10636 3/20 0.35
KDR P35968 2/20 0.35
SLC6A4 P31645 3/20 0.34
KCNH2 Q12809 3/20 0.34
SLC6A2 P23975 1/20 0.34
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 2/20 0.33
HTR2A P28223 2/20 0.33
HPGD P15428 1/20 0.33
GFER P55789 1/20 0.33
TP53 P04637 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
MAPK14 Q16539 1/20 0.33
ACP1 P24666 1/20 0.33
FGFR1 P11362 1/20 0.33
FLT1 P17948 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19984027 0.93 MAPK14 (0.37) MEN1KMT2AMAPTMAPK14POLB
SCHEMBL19984271 0.89 HTR2A (0.34) MEN1KMT2AMAPTKDRSLC6A4
SCHEMBL19983777 0.88 ADRB2 (0.37) MAPK14FBP1
SCHEMBL19983937 0.86 MPO (0.37) MEN1KMT2AMAPTSLC6A4KCNH2
SCHEMBL19984025 0.85 MAPK14 (0.32) MAPTMAPK14
SCHEMBL19983888 0.85 P2RX7 (0.31) SLC6A4KCNH2SLC6A2CYP1A2CYP2C8
SCHEMBL19984022 0.85 AKR1C3 (0.38) MAPTKDRALDH1A1MAPK14POLB
SCHEMBL19984021 0.84 GAK (0.40) MEN1KMT2AKDRSLC6A4KCNH2
SCHEMBL19983901 0.84 TSHR (0.35) MEN1KMT2AMAPTSMN1; SMN2TP53
SCHEMBL19984127 0.84 NUDT1 (0.36) KDRSLC6A4KCNH2SLC6A2FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed